| Date Filed | Type | Description |
| 08/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/31/2023 |
4
| Skvarka Jan (Director) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 41,000 options to buy
@ $7.36, valued at
$301.8k
|
|
| 03/24/2023 |
3
| Skvarka Jan (Director) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
| 01/04/2023 |
4
| Wallace Owen B. (Chief Scientific Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $7.78, valued at
$1.1M
|
|
| 01/04/2023 |
4
| Warmuth Markus (President & CEO) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 472,000 options to buy
@ $7.78, valued at
$3.7M
|
|
| 01/04/2023 |
4
| Nickson Philip (General Counsel) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 123,650 options to buy
@ $7.78, valued at
$962k
|
|
| 01/04/2023 |
4
| Townson Sharon (Chief Technology Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 78,550 options to buy
@ $7.78, valued at
$611.1k
|
|
| 01/04/2023 |
4
| Jones Jullian G (Chief Business Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 77,450 options to buy
@ $7.78, valued at
$602.6k
|
|
| 01/04/2023 |
4
| Castle John C. (Chief Data Scientist) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 78,500 options to buy
@ $7.78, valued at
$610.7k
|
|
| 01/04/2023 |
4
| Tamboli Ajim (CFO) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 129,850 options to buy
@ $7.78, valued at
$1M
|
|
| 01/04/2023 |
4
| Janku Filip (Chief Medical Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 135,000 options to buy
@ $7.78, valued at
$1.1M
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Jones Jullian G (Chief Business Officer) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Granted 73,300 options to buy
@ $13.41, valued at
$983k
|
|
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
3
| Jones Julian G (Chief Business Officer) has filed a Form 3 on Monte Rosa Therapeutics, Inc. |
| 06/30/2021 |
4
| Yang Rick (10% Owner) has filed a Form 4 on Monte Rosa Therapeutics, Inc.|
Txns:
| Converted 2,715,968 shares
@ $0
Converted 3,257,328 shares
@ $0
Converted 669,002 shares
@ $0
Bought 1,050,000 shares
@ $19, valued at
$20M
Converted 9,588,725 convertible preferred
@ $0
Converted 11,500,000 convertible preferred
@ $0
Converted 2,361,912 convertible preferred
@ $0 |
|
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|